Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

PERLA® TL posterior osteosynthesis system

K-Number: K193396 · 2020-02-05

ApplicantSpineart
Decision Date2020-02-05
Product CodeNKB
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

PERLA® TL posterior osteosynthesis system is a medical device manufactured by Spineart. It received FDA 510(k) clearance on 2020-02-05 under approval number K193396. The device is classified under product code NKB. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the PERLA® TL posterior osteosynthesis system?

PERLA® TL posterior osteosynthesis system is a medical device that received FDA 510(k) clearance on 2020-02-05. It is manufactured by Spineart. The 510(k) number is K193396.

When was PERLA® TL posterior osteosynthesis system approved by the FDA?

PERLA® TL posterior osteosynthesis system received FDA 510(k) clearance on 2020-02-05, under approval number K193396.

What company makes PERLA® TL posterior osteosynthesis system?

PERLA® TL posterior osteosynthesis system is manufactured by Spineart.

What is the FDA product code for PERLA® TL posterior osteosynthesis system?

The FDA product code for PERLA® TL posterior osteosynthesis system is NKB.

Related Clinical Trials

Other Devices by Spineart

View all 23 devices →

Related Devices (Code: NKB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.